REG - Oxford Instruments - Sale of Oxford Instruments’ quantum business

Oxford InstrumentsAnnouncement

10/06/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250610:nRSJ1656Ma&default-theme=true

RNS Number : 1656M  Oxford Instruments PLC  10 June 2025

This announcement contains inside information

10 June 2025

 

Oxford Instruments plc

Sale of Oxford Instruments' quantum business, NanoScience

Oxford Instruments plc, a leading provider of high technology products and
services to industry and scientific research communities, today announces that
it has entered into a binding agreement to sell its quantum-focused business
Oxford Instruments NanoScience ("NanoScience") to Quantum Design,
International Inc. for a £60m total cash consideration ("Sale"), including up
to £3m of deferred consideration linked to future revenues from quantum
scaling systems.

In FY25, NanoScience generated approximately £59m(1)() of revenue and £1m(1)
of adjusted operating profit ("AOP"). Having returned the business to growth
and profitability, this Sale crystallises this value for shareholders.

Non-recurring transaction-related costs are expected to be approximately £2m-
£3m in FY2025/26. Following the sale, approximately £4m of cost which is
currently allocated to the NanoScience business will remain within the Group.
We expect to begin to mitigate this in FY2026/27.

The divestment will better enable Oxford Instruments ("the Group") to focus on
its remaining businesses, which have growth and margin characteristics that
will ensure the Group is better placed to deliver value for shareholders.

Given the strength of the balance sheet, the expected cash proceeds from the
sale, and in line with its capital allocation policy, the Group plans to
return up to £50 million to shareholders via a share buyback, commencing
shortly.

Headquartered in the USA, with a global footprint, Quantum Design offers a
range of products and services for scientific, academic and industrial
research.

The sale is subject to regulatory approvals and is expected to complete in the
third quarter of FY2025/26.

CEO Richard Tyson said:

"The sale of our NanoScience quantum business is in line with our strategy to
focus and invest in the best areas of opportunity to grow the Group and create
value for shareholders, and supports progress towards our medium-term margin
targets. It is also consistent with our focus on our three core markets:
materials analysis, semiconductor, and healthcare and life science.

"Quantum Design's desire to lead the business through the next stage of its
development and investment journey is a testament to NanoScience's talented
team and excellent technology."

LEI: 213800J364EZD6UCE231

 

The person responsible for arranging the release of this announcement on
behalf of Oxford Instruments plc is Louise Meads, Interim Company Secretary,
Oxford Instruments plc.

Kroll Securities Ltd acted as exclusive financial advisors to Oxford
Instruments plc on this transaction. Ashurst LLP were retained as legal
counsel.

 

Enquiries:

Oxford Instruments plc

Richard Tyson, Chief Executive Officer

Paul Fry, Chief Financial Officer

Stephen Lamacraft, Head of Investor
Relations
Stephen.lamacraft@oxinst.com (mailto:Stephen.lamacraft@oxinst.com)

 

MHP Group

Katie Hunt/Tim Rowntree/
              07710 117517

Veronica Farah
                                                                     oxfordinstruments@mhpgroup.com
(mailto:oxfordinstruments@mhpgroup.com)
 

 

Notes to Editors

About Oxford Instruments plc

Oxford Instruments provides academic and commercial organisations worldwide
with market-leading scientific technology and expertise across its key market
segments: materials analysis, semiconductors, and healthcare & life
science. Innovation is the driving force behind Oxford Instruments' growth and
success, supporting its core purpose to accelerate the breakthroughs that
create a brighter future for our world. The vigorous search for new ways to
make our world greener, healthier and more productive is driving unprecedented
levels of R&D investment in new materials and techniques to support
productivity and decarbonisation worldwide, creating a significant opportunity
for Oxford Instruments to grow. Oxford Instruments holds a unique position to
anticipate global drivers and connect academic researchers with commercial
applications engineers, acting as a catalyst that powers real world progress.
Founded in 1959 as the first technology business to be spun out from Oxford
University, Oxford Instruments is now a global, FTSE250 company listed on the
London Stock Exchange (OXIG). For more information, visit www.oxinst.com

1 Unaudited figures

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DISPKKBKQBKKNAD